Order results by:
Issue | Title | |
Vol 10, No 6 (2014) | IRBESARTAN IN THE CLINICAL PRACTICE | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..." | ||
Vol 20, No 5 (2024) | The effect of the M235T polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers | Abstract similar documents |
E. V. Rebrova, E. V. Shikh | ||
"... Aim. To study the pharmacodynamic parameters of the effectiveness of therapy with angiotensin II ..." | ||
Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
K. A. Gyamdzhyan, M. L. Maksimov | ||
"... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..." | ||
Vol 20, No 1 (2024) | Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study | Abstract similar documents |
Yu. A. Balanova, S. A. Shalnova, V. A. Kutsenko, A. E. Imaeva, O. E. Ivlev, S. E. Evstifeeva, A. V. Kapustina, M. B. Kotova, S. A. Maksimov, G. A. Muromtseva, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, O. A. Bashkina, S. V. Glukhovskaya, I. A. Levina, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovieva, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, E, V. Mikhailov, Yu. O. Tarabrina, M. G. Ataev, M. O. Radzhabov, Z. M. Gasanova, M. A. Umetov, I. A. Hakuasheva, i. V. Elgarova, E. I. Yamashkina, L. А. Balykova, A. A. Usanova, A. M. Nikitina, N. V. Savvina, Iu. E. Spiridonova, E. A. Naumova, V. S. Yudin, A. A. Keskinov, S. M. Yudin, A. V. Kontsevaya, O. M. Drapkina | ||
"... an informed consent. Results. Among the patients receiving therapy for AH, angiotensin-converting enzyme ..." | ||
Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
"... of hyperactivation of the renin-angiotensin-aldosterone and adrenergic system and endothelial dysfunction ..." | ||
Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
M. Tamirci, R. Demirdamar | ||
"... .1%), angiotensin receptor blockers (ARBs) (22.1%), calcium channel blockers (20.4%), angiotensin converting enzyme ..." | ||
Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
Z M. Sizova | ||
"... Проанализированы современные возможности блокаторов рецепторов AT1 (БРА), в частности, кандесартана ..." | ||
Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
S. A. Boytsov, I. P. Kolos | ||
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..." | ||
Vol 14, No 3 (2018) | COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU | Abstract similar documents |
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca | ||
"... ) inhibitors, then diuretics. The shares of calcium channels blockers (CCB) and angiotensin II receptors ..." | ||
Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta ..." | ||
Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
"... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors ..." | ||
Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
N. A. Dzhaiani | ||
"... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..." | ||
Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
O. D. Ostroumova, I. I. Kopchenov | ||
"... for different clinical situations are presented. Advantages and indications for combination of an angiotensin ..." | ||
Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
M. Loukianov | ||
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta ..." | ||
Vol 13, No 3 (2017) | COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova | ||
"... combinations in both registries were combinations of angiotensin-converting enzyme inhibitors or angiotensin II ..." | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... characteristics were retrospectively assessed, as were the use of renin-angiotensin system inhibitors (RASi ..." | ||
Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
"... Aim. To assess the clinical and anamnestic characteristics, the prescription rate of angiotensin ..." | ||
Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
O. M. Drapkina, E. I. Fomicheva | ||
"... доказанным антигипертензивным эффектом, но и с точки зрения воздействия на метаболические процессы. ..." | ||
Vol 8, No 1 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 | Abstract similar documents |
V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
"... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..." | ||
Vol 8, No 2 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 | Abstract similar documents |
V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
"... inhibit renin–angiotensin–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..." | ||
Vol 16, No 3 (2020) | Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations? | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova | ||
"... data suggesting one of the first line reasonable combinations is the combination of angiotensin ..." | ||
Vol 5, No 5 (2009) | INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
N. V. Egorkina, V. M. Gorbunov, E. S. Abirova | ||
"... in patients with arterial hypertension are presented. Advantages of angiotensin converting enzyme inhibitors ..." | ||
Vol 9, No 6 (2013) | СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN | Abstract similar documents |
I. I. Chukaeva, Ya. G. Spiryakina | ||
"... properties of angiotensin receptor blocker losartan, so it can be used as first-line therapy in patients ..." | ||
Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva | ||
"... antihypertensive therapy with or without renin-angiotensin-aldosterone system (RAAS) inhibitors. Material ..." | ||
Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya | ||
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..." | ||
Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... of the cardiovascular system, which has a variety of mechanisms: dysregulation of the renin-angiotensin-aldosterone ..." | ||
Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
"... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (ACE) inhibitors ..." | ||
Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (ACE) inhibitors keep important ..." | ||
Vol 15, No 4 (2019) | Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study) | Abstract PDF (Eng) similar documents |
Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina | ||
"... . Medications were taken by 65.5% of females and 41.8% of males. Angiotensin-converting enzyme inhibitors were ..." | ||
Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov | ||
"... with single-pill combinations (SPCs) in majority patients with AH. Combination of the angiotensin II receptor ..." | ||
Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
"... and amlodipine, as the reference drug of angiotensin II receptor blockers and calcium channel blockers ..." | ||
Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
"... risk and absence of compelling indications. Results. Angiotensin converting enzyme inhibitors (ACEI ..." | ||
Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
T. Yu. Demidova, O. A. Kislyak | ||
"... importance. The basis of AHT in diabetes and CKD is the combination of a blocker of the renin-angiotensin ..." | ||
Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
M. S. Soboleva, Е. E. Loskutova | ||
"... .8%) and bisoprolol (from 2.4% to 20.3%); in group of angiotensin converting enzyme inhibitors – enalapril (from 3 ..." | ||
Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
E. A. Ryabikhin, M. E. Mozheiko | ||
"... антигипертензивный препарат, снижающий риск сосудистых катастроф и осложнений АГ у больных высокого сердечно ..." | ||
Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
O. V. Dralova, M. L. Maksimov | ||
"... антигипертензивных препаратов, сочетающих в себе высокую эффективность, нейтральный метаболический профиль и высокую ..." | ||
Vol 16, No 3 (2020) | The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril | Abstract similar documents |
A. I. Kochetkov, S. V. Batyukina, O. D. Ostroumova, M. Yu. Nazranova, V. N. Butorov | ||
"... in their stiffness. In addition, excessive blood pressure variability, activation of the tissue renin-angiotensin ..." | ||
Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
"... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..." | ||
Vol 2, No 3 (2006) | COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS | Abstract similar documents |
O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova | ||
"... -hemodynamic effects. Conclusion. The research revealed that the blockage of tissue rennin-angiotensin system ..." | ||
Vol 13, No 6 (2017) | ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina | ||
"... mechanisms of the favorable impact of calcium channel blockers, as well as angiotensin-converting enzyme ..." | ||
Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov | ||
"... single-pill combinations is the combination of an angiotensin II receptor blocker and a calcium channel ..." | ||
Vol 17, No 1 (2021) | Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) | Abstract similar documents |
O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko | ||
"... example of the use of a fixed combination of angiotensin II receptor blocker telmisartan and calcium ..." | ||
Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
"... -angiotensin-aldosterone system (RAAS) blockers, indapamide and calcium channel blocker (CCB) in hypertensive ..." | ||
Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
O. P. Shevchenko, А. О. Shevchenko | ||
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..." | ||
Vol 15, No 2 (2019) | A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist | Abstract similar documents |
S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina | ||
"... В статье рассматриваются современные подходы к выбору тактики антигипертензивной терапии с ..." | ||
Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
"... Цель. Сравнить эффективность фиксированных комбинаций антигипертензивных препаратов в достижении ..." | ||
Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
V. I. Podzolkov, M. V. Pisarev | ||
"... An increase in the activity of the renin-angiotensin-aldosterone system is one of the most ..." | ||
Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
S. Yu. Martsevich | ||
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..." | ||
Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
S. Yu. Martsevich | ||
"... The recent discussion about the dangers of using angiotensin-converting-enzyme (ACE) inhibitors ..." | ||
Vol 16, No 5 (2020) | Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes | Abstract similar documents |
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina | ||
"... antihypertensive therapy for hypertension, as well as angiotensin-converting-enzyme (ACE) inhibitors/angiotensin ..." | ||
Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
"... by prescribing beta-blockers (BB), angiotensin converting enzyme inhibitors (ACEI) and statins. This is reflected ..." | ||
Vol 3, No 4 (2007) | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
I. V. Szirov, E. V. Malichenko | ||
"... Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most ..." | ||
Vol 8, No 2 (2012) | TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..." | ||
Vol 15, No 6 (2019) | Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident | Abstract similar documents |
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
"... ) – HR 0.60 (95%CI 0.42-0.85); angiotensin II receptor blockers (ARB) – HR 0.26 (95%CI 0.13-0.50), beta ..." | ||
Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
S. Yu. Martsevich | ||
"... Comments to the paper G. Savarese et al. A Meta-Analysis Reporting Effects of Angiotensin ..." | ||
Vol 15, No 5 (2019) | Modern Principles of Treatment of Uncontrolled Hypertension | Abstract similar documents |
V. I. Podzolkov, A. I Tarzimanova, Z. O. Georgadze | ||
"... of arterial hypertension in 2018, remain a combination of blockers of the renin-angiotensin-aldosterone system ..." | ||
Vol 13, No 4 (2017) | CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE | Abstract similar documents |
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva | ||
"... The features of the pharmacokinetics of the angiotensin II receptor blocker telmisartan ..." | ||
Vol 18, No 5 (2022) | Comparative Pharmacoepidemiological Assessment of Antihypertensive Drugs Administration Structure in Pregnant Women in Routine Medical Practice in Kursk and Chisinau | Abstract similar documents |
S. V. Povetkin, V. I. Gikavyj, N. G. Bachinski, O. V. Levashova, A. A. Kornilov, L. A. Podgurski, L. M. Tsurkan | ||
"... Цель. Изучить структуру врачебных назначений антигипертензивных средств беременным женщинам с ..." | ||
Vol 5, No 2 (2009) | INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS | Abstract similar documents |
N. A. Nikolaev | ||
"... Обсуждаются инновационные подходы к антигипертензивной фармакотерапии и преимущества современных ..." | ||
Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
Vol 10, No 5 (2014) | USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES | Abstract similar documents |
V. R. Abdrakhmanov, N. I. Gaponova, N. F. Plavunov | ||
"... Обсуждаются результаты клинических исследований, посвященных антигипертензивному действию ..." | ||
Vol 9, No 6 (2013) | SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS | Abstract similar documents |
S. R. Gilyarevskiy | ||
"... Рассматриваются современные подходы к выбору антигипертензивных средств. Обсуждаются вопросы ..." | ||
Vol 8, No 5 (2012) | URAPIDIL IN THE TREATMENT OF MEDICAL EMERGENCIES CAUSED BY BLOOD PRESSURE INCREASE | Abstract similar documents |
N. I. Gaponova, V. R. Abdrakhmanov, S. N. Tereschenko | ||
"... , совмещающему центральный антигипертензивный эффект с периферической вазодилатацией. Отражены области применения ..." | ||
Vol 15, No 2 (2019) | Screening of People with High Blood Pressure in Moscow Region | Abstract similar documents |
O. M. Drapkina, R. N. Shepel, E. S. Ivanova, E. S. Bulgakova, A. N. Kaburova, L. M. Zhamalov, Yu. D. Shalyagin, A. V. Kutcher, S. A. Vernadskiy | ||
"... ), наличие ранее регистрированного повышения АД и факт приема антигипертензивных препаратов. Повышенным АД ..." | ||
Vol 19, No 6 (2023) | Place of imidazoline receptor agonists in the treatment of arterial hypertension | Abstract similar documents |
D. V. Nebieridze, A. S. Safaryan, E. I. Ivanova, E. A. Poddubskaya | ||
"... Обзор посвящен одному из самых дискуссионных вопросов современной антигипертензивной терапии ..." | ||
Vol 16, No 6 (2020) | Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery | Abstract similar documents |
M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev | ||
"... CoA reductase inhibitors and angiotensin-converting-enzyme (ACE) inhibitors/ angiotensin receptor ..." | ||
Vol 5, No 4 (2009) | TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS | Abstract similar documents |
S. V. Malchikova, E. I. Tarlovskaya | ||
"... Цель. Сравнить переносимость различных вариантов комбинированной антигипертензивной терапии у ..." | ||
Vol 7, No 4 (2011) | PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY | Abstract similar documents |
O. V. Dralova, M. L. Maksimov | ||
Vol 10, No 2 (2014) | THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
L. V. Kremneva, O. V. Abaturova, S. V. Shalaev | ||
"... проводимой антигипертензивной терапии, высоком риске развития сердечно-сосудистых осложнений. В задачи ..." | ||
Vol 3, No 1 (2007) | EFFICACY OF DIFFERENT TACTICS FOR INITIAL ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
O. A. Pleyko, A. O. Konrady | ||
"... Цель. Оценить различные алгоритмы подбора рациональной антигипертензивной терапии. Материал и ..." | ||
Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
E. EL. Trisvetova | ||
"... or angiotensin II blockers the good antihypertensive effect with stable BP profile throughout the day ..." | ||
Vol 7, No 4 (2011) | SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION | Abstract similar documents |
S. V. Nedogoda | ||
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..." | ||
Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
I. M. Sokolov, N. A. Zheleznyakova | ||
"... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..." | ||
Vol 16, No 4 (2020) | Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study | Abstract similar documents |
S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih | ||
"... included into the study were analyzed. 90% of patients received angiotensin-converting enzyme inhibitors ..." | ||
Vol 17, No 5 (2021) | Study of the Quality of Medical Therapy and Adherence in Patients with Chronic Heart Failure (According to the COMPLIANCE Study) | Abstract PDF (Eng) similar documents |
E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih, O. M. Drapkina, S. Yu. Martsevich | ||
"... .2%) patients. Angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARBs) were ..." | ||
Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
D. A. Napalkov, E. N. Golovenko | ||
Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
S. N. Tereshchenko, N. A. Dzhaiani | ||
Vol 6, No 3 (2010) | THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova | ||
"... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..." | ||
Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
"... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..." | ||
Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
D. B. Nebieridze, A. S. Safaryan | ||
"... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..." | ||
Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
V. V. Fomin | ||
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..." | ||
Vol 19, No 5 (2023) | Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes | Abstract similar documents |
A. M. Kochergina, O. L. Barbarash | ||
"... , antiplatelet therapy, a beta-blocker, and an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin ..." | ||
Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..." | ||
Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
S. Yu. Martsevich | ||
"... The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis ..." | ||
Vol 10, No 3 (2014) | RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING | Abstract similar documents |
V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva | ||
"... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..." | ||
Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute ..." | ||
Vol 3, No 5 (2007) | EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov | ||
"... Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy ..." | ||
Vol 13, No 6 (2017) | FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES | Abstract similar documents |
D. А. Napalkov, A. A. Sokolova | ||
"... . Possible potentiating effect of angiotensin converting enzyme inhibitors and amlodipine is also discussed ..." | ||
Vol 17, No 4 (2021) | Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" | Abstract similar documents |
M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin | ||
"... минимальными дозами компонентов (у 41,1% пациентов) или с усиленным антигипертензивным или ..." | ||
Vol 6, No 1 (2010) | HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION | Abstract similar documents |
I. V. Osipova, O. N. Antropova, E. I. Bravkova, A. G. Zaltsman, T. B. Belousova, T. V. Perevozchikova, I. A. Batanina | ||
"... . Небиволол у работников локомотивных бригад обладает высокой антигипертензивной эффективностью ..." | ||
Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG) | Abstract similar documents |
O. D. Ostroumova, A. G. Sazonova, K. U. Reznikova, A. V. Srednjakov, E. A. Smolyarchuk | ||
"... . Заключение. Фиксированная комбинация БП и ГХТ имеет высокую антигипертензивную и вазопротективную ..." | ||
Vol 13, No 5 (2017) | CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM | Abstract similar documents |
V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova | ||
"... антигипертензивных препаратов. Возрастание интереса к хронотерапии АГ связано с получением новых сведений о высокой ..." | ||
Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
"... Цель. Изучить антигипертензивный и метаболические эффекты комбинации ингибитора АПФ лизиноприла и ..." | ||
Vol 2, No 1 (2006) | INFLUENCE OF ANTIHYPERTENSIVE THERAPY ON PSYCHOLOGICAL STATUS OF CHERNOBYL NUCLEAR POWER PLANT ACCIDENT CONSEQUENCES LIQUIDATORS | Abstract similar documents |
E. M. Manoshkina, I. I. Razdobreeva, S. K. Kukushkin | ||
"... Цель. Изучить психологический статус и влияние на него антигипертензивной терапии (АГТ) у ..." | ||
Vol 10, No 4 (2014) | QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER | Abstract similar documents |
A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov | ||
"... -поликлинического регистра РЕКВАЗА, обратив особое внимание на соответствие выбора антигипертензивных препаратов ..." | ||
Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
E. L. Trisvetova | ||
"... антигипертензивную эффективность и безопасность лерканидипина, успешно применяемого у пациентов с артериальной ..." | ||
Vol 1, No 3 (2005) | COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
S. Y. Martsevich, J. V. Lukina, A. D. Deev, N. S. Oganisyan, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, V. P. Voronina, M. P. Kozireva | ||
1 - 100 of 377 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)